Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, that video pretty much sums it up. Leronlimab is the miracle cure the world is waiting for, incredible piece of information. EUA coming and the stockpiled vials are gone in 10 minutes. Instant 2 billion in sales plus in no time.
I'm happily buying back in after a potential legal issue with my owning the stock. Looks like I'll be cleared by Tuesday to buy back, just in time for a potential run up! All the denial, lies, and the best is " The Congressman didn't write that letter", all BS. He wrote it and it's verified. Who in their right mind would doubt an EUA for Leronlimab at this point? It's not even the question of is the EUA coming, it's more like, who's first? So many countries. Hopefully our FDA pulls the trigger first.
Wow all that huff and puff in that post and not one true statement. Leronlimab will get it's EUA, no doubt about it
It was confirmed with a phone call from myself to the congressman's office, it's real. He ( they) know and are well informed about Leronlimab
LOL..OK. I guess time will tell and from what I'm hearing, Leronlimab is going to be saving lives soon, share price at 30, and a lot of thankful patients.
No, more like I'm buying Cytodyn after the legal issues with my job title are cleared up, never flipped never will. I still made a killing on it though! Hoping to be cleared by Tuesday, hopefully not to late. I feel the EUA is coming, soon
Ok of course he doesn't he's a Congressman not a doctor or a message baord keyboard warrior, he's a politician who obviously spoke to the FDA if you ask me. It's more than obvious, Leronlimab will get an approval
Naw, not risking my job when the crap hits the fan with certain individuals. Cytodyn is well on it's way and due to recent developments with my career, i decided to sell but after some clarification for legal, I may be back in..soon...without any consequences. But, we'll see about thise lawsuits, soon to be revealed as to who what why and it ain't good for a certain group.
I'm not saying anything but I'd go with he spoke to someone at the FDA to gather that type of info, no?
Sold, I'm kind of not supposed to own due to recent developments. But, you guys are golden, best of luck
You mean the class action lawsuits that are being investigated by The AG's office as to who initiated and possible ties to shorting hedge funds? Mmmmm, I'm gonna bet the house that the investigation shows criminal wrongdoing and Cytodyn then files a suit. Don't under estimate the power of todays technology when it comes to these types of investigations, it's like DNA and fingerprints in electronic forms.
Guess you don't know Davis well, it is what it is at this point, you read it, no denying it's a done deal. Expect EUA at any time. Nader and the Cytodyn team should be proud.
Miss this part?
It is expected that this drug will soon receive authorization permits for the use of the drug.
Sounds like he spoke to someone at the FDA that knows Leronlimab well. Wish I was still a shareholder, proud of the longs, great job!!!
Does it matter if he does or not? He basically just wrote that Leronlimab wins. Game over, bring the EUA on
haha wrong!
Cytodyns Leronlimab has much better numbers and your claim of Lenzil's numbers are false. False numbers, reverse split stinging, ouch!
Cytodyn will see 25-30 in no time.
With number like they have after four doses, this is guaranteed approval, show me a drug for the indications that Leronlimab has with better numbers, there's none.
As far as financing goes, you know that if a BP is financing Cytodyn there's zero disclosure. If they finance a sub of Cytodyn Inc and money filters from one owned corp to another, you'll never know about it.
Making assumptions is dangerous, EUA is on it's way no doubt once the FDA does their DD.
Nuff said as quoted "It will be interesting to see if Brazil adopts both lenzilumab and leronlimab or selects one of the other. Based on the clinical trial result and the MOA leronlimab is the superior drug candidate and probably has less ties to United States pressure to keep it all for themselves.”
i'll say it again, the week isn't over yet and based on the company being very dismissive when asked about trial results, it may be a pump PR.
Leronlimab's numbers are much better and treat a broader range than Lenzil, just a matter of time before the news gets digested and questions will be asked and I have a feeling HGEN's answers are NOT what you are expecting
but but but..no eIND? No OLE? Where's all the good data? Where's all the life saving documented events? Where's all the doctors pushing for it???
Leronlimab will have their EUA very soon, don't blink cause we're going to 50 plus on approval. Lenz will be shelved, who knows, maybe Cytodyn will buy them and re work the drug.
Yup, failed twice, moved goalposts.
Where's their OLE? eIND?
Leronlimab has that.
HGEN stockholders will be disappointed this week
Lenz and HGEN are failures, look at how the trial is panning out.
No OLE or eIND. Leronlimab and the Cytodyn team will get the EUA very soon.
What scientists back Lenz?
There's many in favor of Leronlimab and believe in it. How many for HGEN's Lenzil?
Dr. Gero Hütter, German hematologist, best known for the bone marrow transplant resulting in the cure of the first HIV patient; Dr. Hope S. Rugo, Professor, Department of Medicine (Hematology/Oncology) and Director of the Breast Oncology Clinical Trials Education Program at University of California San Francisco; Dr. Richard T. Maziarz, Professor, Medical Director of the Adult Blood and Marrow Stem Cell Transplant and Cellular Therapy Program Knight Cancer Institute at Oregon Health & Science University (OHSU); Dr. Jonah B. Sacha, Professor, VGTI-Vaccine and Gene Therapy Institute at OHSU; Dr. Mazen Noureddin, a hepatologist and Director, Cedars-Sinai Liver Transplant Program in Los Angeles; Dr. Norman B. Gaylis, nationally and internationally recognized specialist in rheumatology and autoimmune diseases; Dr. Eric D. Mininberg, Oncology Specialist, Piedmont Cancer Institute, a member of the MD Anderson Cancer Network; and Dr. Lishomwa Ndhlovu, Assistant Professor, Immunology, Department of Medicine, Division of Infectious Disease at Weill Cornell Medicine in New York.
Now there's a nice lawsuit for Nader to follow up on, when will people learn you can't jus blab stuff on the web anymore? I'm sure once Nader and the Cytodyn team have time, they'll be announcing lawsuits against everyone who prints trash like this
Wow, just plain disturbing how people assume they know this or that. Charlie is only on Leron and makes about 85 million just on re runs of his hit shows, for christs sake, just stop, ridiculous
LOL..FDA said no to who? What? Cytodyn was given guidance from the FDA, talk about helping out a great drug get to market ASAP.
Lenz is nothing but saline. Leronlimab s the real deal with great trial numbers, Lenz is doomed in phase 3
This was posted on another site..,interesting read..CYDY is on that list....
Jane Street Capital Possible Market Manipulation Info
Many people are aware that almost the entire OTC Market has been crashing in unison for the past month or so. Now we may finally know why. On February 18 and February 22, the Market Maker (MM) JANE appeared on 36 of the highest volume stocks in the OTC. Some examples include OZSC, AITX, GAXY, TSNPD, AABB, ENZC, INKW, OPTI, NSAV, PVDG and WDLF. Later that number increased to 78 stocks. February 22 is also the same day that GME and AMC began trending upward again after a dip that lasted for a couple weeks.
Have you ever noticed that many of your big OTC stocks tend to follow the exact same price curves, dips, spikes and dumps at the same time? This manipulation from JANE is why, and based on the timeline of JANE's appearance in these high volume OTC stocks, the evidence suggests that JANE is heavily manipulating the OTC downward using tactics of naked shorting, dark pool selling and Not-Held Orders in some connection with the fight against retail in GME and AMC.
Please check for yourself by going to https://www.otcmarkets.com/.../broker-dealer-directory/JANE and selecting "Common Stock" from the "Type" drop down menu to view the list of stocks that JANE is in. View the historical charts for many of these stocks and watch them follow the same patterns downward beginning February 22nd.
Significant research has been done on this by https://twitter.com/og_tigress , u/Extlis from the Waypoint Refinery Discord and many others. Pass the word along and up the chain so that we can stop the blatant manipulation by JANE (Jane Street Capital)
And so is our own FDA. Cytodyn will get it hands down
CYDY holding up nicely and still up about 130 percent this year, meanwhile HGEN is tanking- I guess the insiders and market know something
If you look at HGEN's phase 2 and compare with Leronlimab, Leron is far superior, safer and more cost effective.
Failed according to AF? The shirts? Find me one document from either the FDA or Cytodyn that says it failed.
Its an EUA with conditions like every other EUA for COVID 19- sorry if you misunderstand what conditional means when it's used in a sentence describing an action as opposed to a name of something. In fact, I think by Nader calling it conditional he's being very transparent. Leronlimab will be under a conditional EUA with conditions on usage
LOL! Yep, you're right. LOL.
We'll see when the PR that Leronlimab gets a EUA way sooner then HGEN with much better results. Best of luck to HGEN, they are going to need it once it's proven and repeatedly stated CCR5 is key. What does opening the year at 5.69 mean? Is there a significance to the year opening? I said YTD..YEAR TO DATE Leron up 133 percent and HGEN failing miserably. I guess " the market sees it" is true huh?
Lenz has zero eIND's or OLE's and is down 21 percent YTD
Leron has eIND andd OLE and is up 133 percent YTD.
Ok, lets compare-
Lenz will probably file a EUA by years end, Leron did already-
No brainer!!! Cytodyn's Leronlimab for the win
Shadyside Partners LLC from Texas- defunct way back- anyone know if and why they are digging into Cytodyns dealings?
WOW! That is HUGE! Thank You!
How do you know they weren't paid? How do you know they know the potential for sales is a high percentage so hey will wait in good faith for the potential of doing business with Cytodyn when they reach their goals?
Did you forget they are pre revenue?
One click of a mouse and a purchase order for Leronlimab, which we have in stock b the way, puts Cytodyn into orbit with sales literally overnight.
When Cytodyn gets it's EUA with " conditions" or with conditional uses we'll see what it means.
Oh OK..lol..sure, right, so the website must be bogus. LOL. Guess what? That link did not exist yesterday. Like I said, it's positive for Cytodyn regardless of the twisting and bending, approval and sales are coming soon